Detalhe da pesquisa
1.
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
Br J Haematol
; 169(1): 111-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521630
2.
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
Am J Hematol
; 90(3): E40-3, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25400215
3.
Real-life experience of venetoclax and hypomethylating agents in acute myeloid leukemia patients not candidates for intensive chemotherapy or who are refractory/relapsed: A single-centre experience.
Clin Case Rep
; 10(7): e6116, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898750